Geneva Partners, LLC Astrazeneca PLC Transaction History

Geneva Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$69.91 - $75.81 $697,002 - $755,825	9,970 Added 59.6%	26,699 $1.91 Million
Q1 2023 Apr 26, 2023	SELL	$63.15 - $71.6 $11,367 - $12,887	-180 Reduced 1.06%	16,729 $1.16 Million
Q4 2022 Jan 23, 2023	SELL	$54.21 - $70.44 $285,415 - $370,866	-5,265 Reduced 23.74%	16,909 $0
Q3 2022 Oct 31, 2022	SELL	$53.02 - $135.75 $1.42 Million - $3.65 Million	-26,871 Reduced 54.79%	22,174 $1.22 Million
Q2 2022 Jul 25, 2022	BUY	$59.26 - $71.14 $2.91 Million - $3.49 Million	49,045 New	49,045 $3.24 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.